CXCL4 drives fibrosis by promoting several key cellular and molecular processes
2022 · Cell Reports · 71 citations
https://doi.org/10.1016/j.celrep.2021.110189
A
Alsya J. Affandi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
2.0K
Citations
24
h-index
31
i10-index
Alsya J. Affandi is an academic researcher from Cancer Center Amsterdam. The author has contributed to research in topics: Systemic Sclerosis and Related Diseases & Immunotherapy and Immune Responses & Immune cells in cancer. The author has an h-index of 24, co-authored 46 publications.
ORCID: 0000-0003-0859-2322Papers by this author
worksLongitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis
2020 · Journal of Autoimmunity · 32 citations
https://doi.org/10.1016/j.jaut.2020.102574
Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion
2021 · Journal of Controlled Release · 30 citations
https://doi.org/10.1016/j.jconrel.2021.01.029
Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α
2021 · Lara D. Veeken · 20 citations
https://doi.org/10.1093/rheumatology/keab532
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat